These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease. Coughlan MT; Sharma K Kidney Int; 2016 Aug; 90(2):272-279. PubMed ID: 27217197 [TBL] [Abstract][Full Text] [Related]
43. Regulation of endothelial function by mitochondrial reactive oxygen species. Widlansky ME; Gutterman DD Antioxid Redox Signal; 2011 Sep; 15(6):1517-30. PubMed ID: 21194353 [TBL] [Abstract][Full Text] [Related]
44. Increased reactive oxygen species production during reductive stress: The roles of mitochondrial glutathione and thioredoxin reductases. Korge P; Calmettes G; Weiss JN Biochim Biophys Acta; 2015; 1847(6-7):514-25. PubMed ID: 25701705 [TBL] [Abstract][Full Text] [Related]
45. Mitochondria and NADPH oxidases are the major sources of TNF-α/cycloheximide-induced oxidative stress in murine intestinal epithelial MODE-K cells. Babu D; Leclercq G; Goossens V; Vanden Berghe T; Van Hamme E; Vandenabeele P; Lefebvre RA Cell Signal; 2015 Jun; 27(6):1141-58. PubMed ID: 25725292 [TBL] [Abstract][Full Text] [Related]
46. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. Wong HS; Dighe PA; Mezera V; Monternier PA; Brand MD J Biol Chem; 2017 Oct; 292(41):16804-16809. PubMed ID: 28842493 [TBL] [Abstract][Full Text] [Related]
47. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. Coughlan MT; Thorburn DR; Penfold SA; Laskowski A; Harcourt BE; Sourris KC; Tan AL; Fukami K; Thallas-Bonke V; Nawroth PP; Brownlee M; Bierhaus A; Cooper ME; Forbes JM J Am Soc Nephrol; 2009 Apr; 20(4):742-52. PubMed ID: 19158353 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Bravard A; Bonnard C; Durand A; Chauvin MA; Favier R; Vidal H; Rieusset J Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E581-91. PubMed ID: 21224483 [TBL] [Abstract][Full Text] [Related]
49. The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications. Zhang Z; Huang Q; Zhao D; Lian F; Li X; Qi W Front Endocrinol (Lausanne); 2023; 14():1112363. PubMed ID: 36824356 [TBL] [Abstract][Full Text] [Related]
50. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Sivitz WI; Yorek MA Antioxid Redox Signal; 2010 Apr; 12(4):537-77. PubMed ID: 19650713 [TBL] [Abstract][Full Text] [Related]
51. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. Yan LJ J Diabetes Res; 2014; 2014():137919. PubMed ID: 25019091 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of disease: Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes. Fernyhough P; McGavock J Handb Clin Neurol; 2014; 126():353-77. PubMed ID: 25410234 [TBL] [Abstract][Full Text] [Related]
53. Nutrient Metabolism, Subcellular Redox State, and Oxidative Stress in Pancreatic Islets and β-Cells. Roma LP; Jonas JC J Mol Biol; 2020 Mar; 432(5):1461-1493. PubMed ID: 31634466 [TBL] [Abstract][Full Text] [Related]
54. Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy. Ni R; Zheng D; Xiong S; Hill DJ; Sun T; Gardiner RB; Fan GC; Lu Y; Abel ED; Greer PA; Peng T Diabetes; 2016 Jan; 65(1):255-68. PubMed ID: 26470784 [TBL] [Abstract][Full Text] [Related]
55. Introduction to the Thematic Minireview Series: Redox metabolism and signaling. Banerjee R J Biol Chem; 2017 Oct; 292(41):16802-16803. PubMed ID: 28842492 [TBL] [Abstract][Full Text] [Related]